Speaker: 

Dilleswar Rompivalsa, MD Resident Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Objective

• 1. Discuss the role of prophylactic antiseizure medications in traumatic brain injury (TBI).

  2. Determine the association between seizure prophylaxis and risk reduction for early post-traumatic seizures (PTS) in mild and moderate TBI.

• Questions 

  1. Do you believe we need to treat every TBI case with prophylactic antiseizure medications?

     2. If you choose to treat TBI with prophylactic antiseizure medications, what would be your go-to drug?

     3. Do you think the same approach applies to our stroke patients with massive infarcts or hemorrhages?

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Dana Vanino, DO; Cortney Houtz, LPN; Joy Hill, RN and Kristy Heim have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.